據(jù)外媒報(bào)道，法國(guó)衛(wèi)生部門(mén)4日表示，暫停銷(xiāo)售一款維生素D補(bǔ)充劑，因?yàn)楫a(chǎn)品有可能導(dǎo)致一名嬰兒死亡。

據(jù)報(bào)道，一名嬰兒在服用補(bǔ)充嬰幼兒維生素D不足的UvesterolD補(bǔ)充劑后，于2016年12月21日死亡。

法國(guó)衛(wèi)生部長(zhǎng)圖雷(MarisolTouraine)稱，為避免風(fēng)險(xiǎn)，法國(guó)國(guó)家藥品安全管理局(ANSM)作出了這項(xiàng)決定。該局在之前就曾針對(duì)這種補(bǔ)充劑發(fā)布警告。

部分原文報(bào)道如下：

Sales of a vitamin D medication are set to be suspended in France following the death of a baby who suffocated after taking the liquid supplement.

Health authorities announced today that the measure was being taken 'as a precaution'.

Investigations found 'a probable link between the death and the administration of Uvesterol D', France's ANSM health agency revealed.